While some cereals may be the breakfast of champions, a UBC professor suggests people with Type 2 Diabetes (T2D) should be reaching for something else. Associate Professor Jonathan Little, who teaches in UBC Okanagan's School of Health and Exercise Sciences, published a study this week demonstrating that a high-fat, low-carb breakfast (LCBF) can help those with T2D control blood sugar levels throughout the day.
Lowering low-density lipoprotein (LDL) cholesterol reduces the risk of heart attacks and stroke, with an ideal value below 100 milligrams per deciliter (mg/dL). But can it be too low? A new study finds that women who have levels of LDL cholesterol 70 mg/dL or lower may be more than twice as likely to have a hemorrhagic stroke than women with LDL cholesterol levels from 100 to 130 mg/dL.
According to a study published today by a Finnish-English research group, a switch from 5-yearly screen intervals to individualized intervals could annually prevent 8 percent of myocardial infarcts and strokes without increasing health care costs.
Liquid meal replacements helped overweight diabetes patients lose an average of about five pounds more than others who tried a conventional low-calorie diet, according to a meta-analysis of randomized controlled trials.
Teens who sit for hours watching TV, using the computer or playing video games while eating unhealthy snacks are at increased risk for a group of risk factors for heart disease and diabetes, according to research to be presented Monday, March 25, at ENDO 2019, the annual meeting of the Endocrine Society, in New Orleans, La.
New study in mice by University of Illinois researchers finds that the compounds in thermally abused cooking oils may trigger genetic, biochemical changes that hasten the progression of late-stage breast cancer, promoting tumor cells' growth and proliferation.
Experiments with mice suggest that treatment with atorvastatin can attenuate adipose tissue remodeling, leading to rapid weight loss and muscle atrophy.
By suppressing the activity of key cellular receptors called G protein-coupled receptors (GPCRs) and their interacting partners called G proteins, statins have the potential to alter various bodily functions controlled by this important pathway, according to researchers at The University of Toledo.
Patients at high risk for a heart attack or stroke who took an investigational drug in addition to a statin had significantly lower LDL, or 'bad' cholesterol, after 12 weeks compared to similar patients who took a placebo in addition to statin therapy, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.
In a new study from the Intermountain Healthcare Heart Institute in Salt Lake City, researchers have identified eight new gene mutations that may cause or contribute to idiopathic dilated cardiomyopathy, a form of heart disease not caused by known external influences, such as high blood pressure, obesity, smoking, or diseased coronary arteries.